LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

19th August 2026

Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen’s University to Treat GM2 Gangliosidoses

18th August 2026

Bespak Awarded Gold EcoVadis Sustainability Rating for its Holmes Chapel Site

18th August 2026

Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

18th August 2026

CPHI & PMEC Shenzhen 2026 attracts unprecedented international interest as demand for AI-driven innovation grows

18th August 2026

ACG appoints Rajesh Bhogavalli as Group Chief Commercial Officer New Group Chief Commercial Officer to support next phase of international growth

18th August 2026

Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited

17th August 2026

Lonza Launches Rapid Custom Media Prototyping Service to Accelerate Early Bioprocess Development

14th August 2026

Axplora's sustainability strategy substantiated by SBTi as company accelerates action across its manufacturing network

13th August 2026

Prescient completes integration of Uptake and Dolon under single global brand

13th August 2026

Pace ® appoints Andy Fenny as President of Pace ® Life Sciences to drive strategic growth

11th August 2026

Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations